Buy & Sell Krispy Kreme Inc (DNUT) – Krispy Kreme Inc Price Today
Aura AI Summary
Key Stats
- $651.15MMarket Cap
- Consumer StaplesSector
- -21.78%3M Drawdown
- $1.85BEnterprise Value
- 3.47%Dividend Yield
- 80% Buy | 20% SellTrading Activity
- 39 daysTypical Hold Time
Krispy Kreme Inc (DNUT) is currently valued at a market capitalization of $651.15M, with an enterprise value of $1.85B. Over the past 52 weeks, Krispy Kreme Inc has traded between a low of $2.57 and a high of $4.7, highlighting its annual price range. Over the past three months, Krispy Kreme Inc has recorded a drawdown of -21.78%, reflecting recent price volatility. Krispy Kreme Inc offers a dividend yield of 3.47%, with the most recent dividend of $0.04 paid on 23 Apr 25. On average, investors hold Krispy Kreme Inc for approximately 39 days, indicating typical investor behavior on the platform.
About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Most Recent News
Over 100 drugs in clinical trials aim to transform age-related macular degeneration treatment by 2026
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...

Cell and gene therapy CDMO market set to grow at 24% CAGR, reaching $57.1B by 2034.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...

Polymeric biomaterials market to hit $267B by 2034, driven by regenerative medicine and healthcare growth.
The global polymeric biomaterials market, valued at $69.55 billion in 2024, is projected to grow at a CAGR of 15.86% to reach $267.25 billion by 2034. Growth is fueled by increasing demand in regenerative medicine, orthopedics, and wound care, with A...
